Literature DB >> 22375415

[Current status of non-viral vectors for siRNA delivery].

Fei-Fei Yang1, Wei Huang, Yun-Fei Li, Zhong-Gao Gao.   

Abstract

RNA interference (RNAi) is a newly developed technology. It is the different levels of gene silencing induced by specific degradation of targeted genes in vivo, and both exogenous and endogenous double-stranded RNAs could induce the specific degradation. RNAi has been applied in tumor therapy, viral infection, hepatitis B and many other diseases. siRNA is the effector molecule which induces the RNAi in vivo. But naked siRNA is easily degradated by RNases in vivo, and the half-life is short. Meanwhile, the transfection efficiency of the naked siRNA is comparatively low. So the naked siRNA needs the help of vectors to penetrate the cell membrane and take action. Viral vectors have the potential immunogenicity and mutagenicity in gene therapy. Therefore, non-viral vectors are drawing more and more attention. The latest development of the non-viral vectors is summarized in this review.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22375415

Source DB:  PubMed          Journal:  Yao Xue Xue Bao        ISSN: 0513-4870


  3 in total

1.  Inhibition of HCV 5'-NTR and core expression by a small hairpin RNA delivered by a histone gene carrier, HPhA.

Authors:  Yanhua Ding; Hong Zhang; Yuxiang Li; Di Wu; Shumei He; Yang Wang; Yuanyuan Li; Feng Wang; Junqi Niu
Journal:  Int J Med Sci       Date:  2013-06-09       Impact factor: 3.738

2.  Serial Measurements of Apoptotic Cell Numbers Provide Better Acceptance Criterion for PBMC Quality than a Single Measurement Prior to the T Cell Assay.

Authors:  Marie Wunsch; Richard Caspell; Stefanie Kuerten; Paul V Lehmann; Srividya Sundararaman
Journal:  Cells       Date:  2015-01-09       Impact factor: 6.600

3.  Retinoic acid receptor α expression exerts an anti-apoptosis effect on PC12 cells following oxygen-glucose deprivation.

Authors:  Wanliang Dong; Yuankun Zhang
Journal:  Exp Ther Med       Date:  2018-08-22       Impact factor: 2.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.